Endothelial Dysfunction in Diabetes Mellitus: New Insights
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Endothelial dysfunction (ED) is an important marker of future atherosclerosis and cardiovascular disease, especially in people with diabetes. This article summarizes the evidence on endothelial dysfunction in people with diabetes and adds different perspectives that can affect the presence and severity of ED and its consequences. We highlight that data on ED in type 1 diabetes are lacking and discuss the relationship between ED and arterial stiffness. Several interesting studies have been published showing that ED modulates microRNA, microvesicles, lipid levels, and the endoplasmatic reticulum. A better understanding of ED could provide important insights into the microvascular complications of diabetes, their treatment, and even their prevention.
Zheng H, Yu J, Gao L, Wang K, Xu Z, Zeng Z Nat Commun. 2025; 16(1):1826.
PMID: 39979282 PMC: 11842847. DOI: 10.1038/s41467-025-57124-x.
Verma S, Sen C, Srivastava R, Gnyawali S, Katiyar P, Sahi A Mol Ther. 2025; 33(3):950-969.
PMID: 39863930 PMC: 11897775. DOI: 10.1016/j.ymthe.2025.01.034.
Boieriu A, Luca C, Neculoiu C, Bisoc A, Tint D Medicina (Kaunas). 2025; 61(1).
PMID: 39859119 PMC: 11767194. DOI: 10.3390/medicina61010135.
Jin C, Tian Z Am J Transl Res. 2025; 16(12):8032-8042.
PMID: 39822498 PMC: 11733351. DOI: 10.62347/LCRY8746.
Liu B, Li M, Liu J, Xie L, Li J, Liu Y Rev Cardiovasc Med. 2025; 25(12):458.
PMID: 39742219 PMC: 11683691. DOI: 10.31083/j.rcm2512458.